Cargando…

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors

Uterine smooth muscle tumors range from benign leiomyomas to malignant leiomyosarcomas. Based on numerous molecular studies, leiomyomas and leiomyosarcomas mostly lack shared mutations and the majority of tumors are believed to develop through distinct mechanisms. To further characterize the molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mäkinen, Netta, Kämpjärvi, Kati, Frizzell, Norma, Bützow, Ralf, Vahteristo, Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463371/ https://www.ncbi.nlm.nih.gov/pubmed/28592321 http://dx.doi.org/10.1186/s12943-017-0672-1

Ejemplares similares

MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
por: Kämpjärvi, Kati, et al.
Publicado: (2016)

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
por: Mäkinen, Netta, et al.
Publicado: (2016)

Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018)

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
por: Kämpjärvi, K, et al.
Publicado: (2012)

3′RNA and whole‐genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1
por: Jokinen, Vilja, et al.
Publicado: (2022)

Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas
por: Mäkinen, N, et al.
Publicado: (2014)

Prevalence and clinical significance of co-existing mutations in MED12 and FH in uterine fibroids of Australian women
por: Jamaluddin, M. Fairuz B., et al.
Publicado: (2023)

MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma
por: Bertsch, Elizabeth, et al.
Publicado: (2014)

Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
por: Kämpjärvi, Kati, et al.
Publicado: (2014)

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients
por: Mäkinen, Netta, et al.
Publicado: (2011)

3′RNA Sequencing Accurately Classifies Formalin-Fixed Paraffin-Embedded Uterine Leiomyomas
por: Mehine, Miika, et al.
Publicado: (2020)

Global metabolomic profiling of uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
por: Pasanen, Annukka, et al.
Publicado: (2021)

Common Variable Immunodeficiency and Circulating T(FH)
por: Coraglia, Ana, et al.
Publicado: (2016)

Cytogenetically normal uterine leiomyomas without MED12-mutations – a source to identify unknown mechanisms of the development of uterine smooth muscle tumors
por: Holzmann, Carsten, et al.
Publicado: (2014)

Novel FH mutation associated with multiple uterine leiomyomas in Chinese siblings
por: Zhao, Zichen, et al.
Publicado: (2019)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
por: Pérot, Gaëlle, et al.
Publicado: (2012)

A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase
por: Mehine, Miika, et al.
Publicado: (2022)

Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata
por: Firdaus, Ruqia, et al.
Publicado: (2021)

Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors
por: Hoekstra, Attje S., et al.
Publicado: (2015)

Functional Characterization of FH Mutation c.557G>A Underlies Uterine Leiomyomas
por: Li, Ping, et al.
Publicado: (2022)

Parity associates with chromosomal damage in uterine leiomyomas
por: Kuisma, Heli, et al.
Publicado: (2021)

Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas
por: Moyo, Mthabisi B., et al.
Publicado: (2020)

Analysis of MED12 Mutation in Multiple Uterine Leiomyomas in South Korean patients
por: Lee, Minkyoung, et al.
Publicado: (2018)

Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas
por: Chuang, Tsai-Der, et al.
Publicado: (2023)

Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry
por: Reyes, Carolina, et al.
Publicado: (2013)

Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma
por: Shi, Guizhi, et al.
Publicado: (2009)

MED12 Regulates Smooth Muscle Cell Functions and Participates in the Development of Aortic Dissection
por: Zhou, Yingchao, et al.
Publicado: (2022)

FH through the retrospectoscope
por: Thompson, Gilbert R.
Publicado: (2021)

Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021)

Aberrant R-loop-induced replication stress in MED12-mutant uterine fibroids
por: Muralimanoharan, Sribalasubashini, et al.
Publicado: (2022)

HMGA2 overexpression is associated with differential expression of miRNAs in uterine leiomyomas
por: Mello, Julia BH, et al.
Publicado: (2013)

The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry
por: Alallaf, Faisal, et al.
Publicado: (2017)

Tox2 is required for the maintenance of GC T(FH) cells and the generation of memory T(FH) cells
por: Horiuchi, Shu, et al.
Publicado: (2021)

Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas
por: Barker, K T, et al.
Publicado: (2002)

Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women
por: Ajabnoor, Ghada M. A., et al.
Publicado: (2018)

Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status
por: Hutchinson, Anne P., et al.
Publicado: (2022)

Different DNA methylome, transcriptome and histological features in uterine fibroids with and without MED12 mutations
por: Maekawa, Ryo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfplaufemt8nd9se6knql84n7q